Breaks in the wall: increased gaps in the intestinal epithelium of irritable bowel syndrome patients identified by confocal laser endomicroscopy (with videos)
This alarming figure is a result of the aging population, which is more likely to develop T2D, together with population-wide lifestyle changes, and also reflects the fact that T2D is being diagnosed earlier and, with advances in management strategies, patients are living longer [1]
The needle is very thin and short, making the injection nearly painless
Medicaid programs in some states cover weight loss medications, and the VA covers a variety of options
Food and Drug Administration approved the first GLP-1 drug for type 2 diabetes in 2005 and another, the first for weight loss, in 2014